Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile

Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP

Neuropsychiatric Disease and Treatment 2024, 20:923-936

Published Date: 3 May 2024

Original Research

Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson’s Disease: A Cross-Sectional Study

Ouyang Q, Xu L, Zhang Y, Huang L, Li L, Yu M

Neuropsychiatric Disease and Treatment 2024, 20:913-921

Published Date: 30 April 2024

Original Research

Added Clinical Value of Intraplaque Neovascularization Detection to Color Doppler Ultrasound for Assessing Ischemic Stroke Risk

Cui L, Liu R, Zhou F, Liu Y, Tian B, Chen Y, Xing Y

Neuropsychiatric Disease and Treatment 2024, 20:899-909

Published Date: 23 April 2024

Letter

Brain Temperature, Choline, N-Acetyl-Aspartate, and Myo-Inositol Measured by MRS Can Only Be Considered Diagnostic Biomarkers if Their Criteria are Met [Letter]

Finsterer J

Neuropsychiatric Disease and Treatment 2024, 20:897-898

Published Date: 22 April 2024

Original Research

Building and Validation of an Acute Event Prediction Model for Severe Mental Disorders

Wang T, Wang L, Yao Y, Liu N, Peng A, Ling M, Ye F, Sun J

Neuropsychiatric Disease and Treatment 2024, 20:885-896

Published Date: 17 April 2024